Value is a concept that concerns all healthcare stakeholders.
In this webinar Zitter Health Insights will deconstruct script abandonment and provide you key findings around the impact on patient outcomes.
In this webinar, we'll discuss how mobile apps are changing the healthcare journey for patients and visitors from all walks of life.
Join other industry leaders to gain insight on this new medical social phenomenon.
Regeneron's Eylea won its fourth indication; Sun Pharma wants to revive trust in its products; confidentiality agreements keep Amgen from telling patients their cancer risk
The orphan-drug market was flying high before President Obama announced plans to devote $215 million to the funding of a Precision Medicine Initiative. Imagine the excitement among interested audiences now that those plans have picked up momentum. Frank Celia reports
Panelists at a healthcare innovation conference said clinical research and local physician practices need to do more for women's health.
Direct-to-patient approaches can positively impact real world and late phase research programs to increase engagement, retention and data collection.
The drugmaker inks deal with Novo Nordisk to access its biologic discovery research platform.
Keytruda trial stopped due to positive results; new bill proposes continuing FDA rare pediatric voucher program; AstraZeneca signs five-year research pact with Harvard Stem Cell Institute
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
- US pharma market value projected to be $550 billion in five years
- Biosimilar uptake will require companies to tell a trustworthy backstory
- Lawmakers propose allowing pharma companies to share some off-label information
- Apple's ResearchKit: Five Guidelines for Pharma
- Everyday Health buys rare-disease agency Cambridge BioMarketing
- Five things for pharma marketers to know: Thursday, March 26
- Rare Diseases: Target Practice
- Physicians call for emphasis on women's health research and care
- Implement a Direct-to-Patient Approach to Increase Patient Engagement and Retention
- Bristol-Myers Squibb licenses autoimmune program from Novo Nordisk